Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Income from licenses are twice as high as previously estimated

I'm not sure I understand what you're getting at. If you think that the J's do NOT have licenses for the MMP, then based on the SEC filings, the PR's issued, the clarifications by IR, the commentary by the company, etc. etc., I'd have to say definitively, that is not correct.


If you're questioning whether the J's actually paid anything for their licenses, obviously, that MIGHT be an argument that you can make, but if you look at the other 9 companies that are on that roster of Q3 licenses, to expect that they paid $27M between them and J's nothing, consideirng the size and who those other companies are, I think is unrealistic. I think the J's paid, I just think they got a SWEET deal, but for a good reason. What that reason is would be quite revealing if we can ever figure it out.

Share
New Message
Please login to post a reply